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Abstract
Background: Bony defects arising from tumor resection or debridement after infection, non-
union or trauma present a challenging problem to orthopedic surgeons, as well as patients due to
compliance issues. Current treatment options are time intensive, require more than one operation
and are associated with high rate of complications. For this reason, we developed a new surgical
procedure to bridge a massive long bone defect.
Methods: To bridge the gap, an in situ periosteal sleeve is elevated circumferentially off of healthy
diaphyseal bone adjacent to the bone defect. Then, the adjacent bone is osteotomized and the
transport segment is moved along an intramedullary nail, out of the periosteal sleeve and into the
original diaphyseal defect, where it is docked. Vascularity is maintained through retention of the
soft tissue attachments to the in situ periosteal sleeve. In addition, periosteal osteogenesis can be
augmented through utilization of cancellous bone graft or in situ cortical bone adherent to the
periosteal sleeve.
Results: The proposed procedure is novel in that it exploits the osteogenic potential of the
periosteum by replacing the defect arising from resection of tissue out of a pathological area with
a defect in a healthy area of tissue, through transport of the adjacent bone segment. Furthermore,
the proposed procedure has several advantages over the current standard of care including ease
of implementation, rapid patient mobilization, and no need for specialized implants (intramedullary
nails are standard inventory for surgical oncology and trauma departments) or costly
orthobiologics.
Conclusions: The proposed procedure offers a viable and potentially preferable alternative to the
current standard treatment modalities, particularly in areas of the world where few surgeons are
trained for procedures such as distraction osteogenesis (e.g. the Ilizarov procedure) as well as areas
of the world where surgeons have little access to expensive, complex devices and orthobiologics.
Background
Replacement of bone where there is none is one of the
most challenging problems facing orthopedic surgeons
today. In the case of tumor resection or trauma, massive
bone defects must be filled with regenerate bone as
quickly as possible in order to restore function. Current
standards for bridging of massive bone defects in long
bones generally follow a theme of i) filling the defect with
bone autograft or allograft (including cancellous bone
graft or bone transplantation via vascularized or non-vas-
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cularized fibula transfer) and ii) accelerating functional
remodeling and integration through addition of physical
and/or chemical stimuli such as tension (e.g. Ilizarov
technique, which is a standard surgical treatment modal-
ity for bone transport whereby an osteotomy is performed
far from the defect site and the transport segment thus cre-
ated is moved, approximately one millimeter per day,
under the constant tension by wires attached to a cumber-
some external fixator, until the defect is bridged and the
segment can be docked onto the other side of the defect),
and orthobiologics (e.g. bone graft or bone graft replace-
ment, BMP's). Surgical treatment modalities involving
auto/allografting and bone regeneration via distraction
osteogenesis are complex, time intensive procedures of
inherently high risk due to vagaries of organ donation, in
the case of allografts, and the complexity of soft and hard
tissue salvage during the process of distraction osteogene-
sis. In addition, orthobiologics are costly and their dosage
regimes as well as efficacy are currently the subject of
much research [1-3].
Both bone grafting and bone transport procedures are
complex for the surgeon as well as for the patient. Further-
more, they are susceptible to complications such as
delayed union, extensive treatment time periods, infec-
tions, and insufficient mechanical function outcomes that
can result in fractures. The high complication rates of
these procedures exacerbate the previously mentioned dif-
ficulties associated with these treatment modalities, from
the perspective of the surgeon as well as that of the
patient. In short, the inherent risk of complications
increases the need for patient compliance and clinical fol-
low-up. Despite the effort associated with these proce-
dures, their results are often less than satisfactory. Hence,
the complexity and shortcomings of current state-of-the-
art surgical procedures have provided impetus to develop
a new treatment modality that provides a relatively
straightforward, single step procedure with a high proba-
bility of success for the bridging of massive bone defects
in long bones. The procedure is straightforward and can
be implemented in operating rooms across the world
without the need for high-tech equipment or expensive
orthobiologics. The purpose of this manuscript is to
describe the novel procedure.
Technical innovation – methodology and proof 
of feasibility
The proposed procedure is applicable for clinical scenar-
ios including tumor resection as well as debridement after
an infection or non-union. In the case of reconstruction
after tumor resection (Fig. 1A), a transport-segment of the
diaphysis adjacent to the defect is pealed out of the sur-
rounding periosteum (Fig 1B,C), an osteotomy is per-
formed and the transport-segment is moved out of the
periosteal sleeve and docked to the other side of the defect
(Fig. 1D). The periosteal sleeve is then closed like a tube
surrounding the newly created defect. Either an internal
fixation device such as an intramedullary nail, a plate or
an internal fixator or an external fixator can be used to
provide stabilization through the healing and regenera-
tion phase.
The proposed procedure depends to a large degree on
bone's inherent healing strategies. Bone is a remarkably
resilient tissue capable of adaptation to the most extreme
biological and mechanical environments; this capacity for
self-regeneration without scarring is based on bone's
endogenous healing strategies. First, bone remodels itself
through osteoclastic resorption and osteoblastic matrix
apposition; by constantly reweaving itself, the structure is
dynamic and optimal for prevailing mechanical function.
Furthermore, the natural healing cascade of bone after
trauma recapitulates embryonic endochondral ossifica-
tion. Hence, modeling, growth and remodeling confer a
means to regenerate functional tissue at any time in the
life cycle of a bone. The "raw materials" necessary to
replace bone are located in the environment or produced
by the cells that do the work of regeneration, i.e. osteo-
clasts and osteoblasts. In the case of regeneration of bone
in defects, further potentially key constituents to the for-
mation of a functional regenerate in situ include a patent
blood supply, chemical gradients of morphogens and/or
cytokines, a template onto which the cells can anchor
themselves during the rebuilding process (e.g. graft or a
scaffold), and biophysical stimuli such as fluid flow and/
or cell level strains. The proposed procedure essentially
replaces the defect site in a pathological zone with a defect
site in a healthy bed of tissue and provides for progenitor
cells through the surrounding, healthy periosteum as well
as many of the other key constituents for successful tissue
regeneration, as defined above.
A clinical case described below demonstrates the osteoin-
ductive potential of the periosteum and serves is a proof of
feasibility for the proposed procedure. An 11-year old male
presented with a low grade surface osteosarcoma of the
tibia. After resection of the tumor, the fibula was resected
for transfer and the surrounding periosteum was left
behind to serve as an osteo-inductive and -conductive
sleeve (Figure 2A). Already 3 weeks after the procedure,
bone regenerate is visible within this sleeve (Figure 2A).
Impressive remodeling of the fibula is also evident in fol-
low up radiographs and includes extensive remodeling of
the intramedullary canal by three months post procedure
(Figure 2B and 2C). Based on this clinical case as well as
one author's previous experience with an in vivo segmental
defect in an ovine model [4,5], the osteogenic potential of
the periosteum as a source of progenitor cells and as a
"membrane" or boundary template for guided bone gen-
eration is demonstrated. Taking this one step further, theWorld Journal of Surgical Oncology 2005, 3:7 http://www.wjso.com/content/3/1/7
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corresponding author conceived of the idea to exploit the
potential of the healthy periosteum by moving the defect
site from a pathological zone to a healthy one and then
providing sufficient mechanical stability to let bone's
endogenous healing capacity regenerate functional tissue
within the new defect zone.
Discussion
The proposed procedure is novel in that it introduces for
the first time the possibility to bridge a massive defect in
a long bone using a single stage procedure. Furthermore,
the proposed procedure has several advantages over the
current standard of care including ease of implementa-
tion, lack of requirement for specialized implants
(intramedullary nails are standard inventory for surgical
oncology and trauma departments) or costly orthobio-
logics, and rapid patient mobilization. This makes the
proposed procedure a viable and potentially preferable
alternative to the current standard treatment modalities,
particularly areas of the world where few surgeons are
trained for procedures such as distraction osteogenesis
(e.g. the Ilizarov procedure) as well as where surgeons
have less access to expensive, complex devices and
orthobiologics.
Conclusion
In summary, the authors propose a new procedure which
obviates the need for several surgical procedures, reduces
the risk for complications, reduces the time frame for the
treatment and is much more comfortable for and requires
less compliance of the patient. This novel, one stage pro-
cedure exploits the osteogenetic potential of the
Schematic diagram showing the concept for the new surgical procedure Figure 1
Schematic diagram showing the concept for the new surgical procedure.World Journal of Surgical Oncology 2005, 3:7 http://www.wjso.com/content/3/1/7
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11 year male with malignant tumor Figure 2
11 year male with malignant tumor. Fibula-pro-tibia following local resection. Cortical regeneration from periosteum. Per-
formed at Mt. Sinai Medical Center, NYC, 2000. A: 3 weeks post-operative radiograph, B: 6 weeks post-operative, C: 3 
months post-operative, D: approximately 6 months post-operative.Publish with BioMed Central    and   every 
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periosteum for bone formation to bridge the defect with
concomitant bone transport and does not require the use
of expensive hardware or orthobiologics.
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